Here's why the NOVONIX FPO share price is up 130% in 2017

Will the NOVONIX FPO (ASX:NVX) share price rise further or should you avoid it entirely?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Following a corporate rebrand, the NOVONIX FPO (ASX: NVX) share price has skyrocketed 130% to $1.27 so far this year. Formerly known as Graphitecorp Limited, shares have boomed after the acquisition of Novonix, a player in the battery and electric vehicle industry.

Novonix is now aiming to "leverage the strong NOVONIX brand name in the battery industry where it is well known for manufacturing the world's most accurate battery cell testing equipment and for providing outstanding quality and customer service."

The recent quarterly update was full of optimism and positive updates regarding the battery industry, quoting recent decisions by Volkswagen to go mainstream with its electrical vehicles, and Volvo's decision to exit pure petrol vehicles entirely by 2020. Novonix obviously foresees big growth in demand for its services. However, I would sound a note of caution for investors as Novonix has not yet released its most recent quarterly report to show how much it might be earning.

Furthermore, the company's most recent quarterly report in April showed zero revenues, cash outflows of $1.4m in the 9 months year to date, and just $1.4 million cash at bank.

The battery servicing business may prove to be an interesting opportunity – the 'picks and shovels' strategy of providing ancillary services to an industry is typically better than the industry itself, particularly where the industry is highly competitive (electric vehicles) and/or commodity-focused (graphite).

However, in my view Novonix is not investment grade and I would wait at least to see a couple of quarterly reports (the next one should be out very soon) before deciding whether to buy its shares. At present, in my opinion the share price is founded largely on hype.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »